A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Conditions
- Myelodysplastic Syndromes (MDS)
- Beta-thalassemia
- Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Interventions
Sponsor
Celgene